Skip to content

Clinical trials

Phase 4 Coronary Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 4 Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20113
20123
20131
20141
20153
20163
20193
20201
20212
20221
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15
Completed12
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases4
Abbott Medical Devices2
Beijing Anzhen Hospital2
Shanghai Hutchison Pharmaceuticals Limited2
Chinese PLA General Hospital1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Fu Wai Hospital, Beijing, China1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Guangdong Provincial Hospital of Traditional Chinese Medicine1
Han Yaling1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease32
Coronary Artery Disease7
Acute Coronary Syndrome3
Angina Pectoris3
Coronary Stenosis3
Myocardial Ischemia3
Vascular Diseases3
Angina, Stable2
Cardiovascular Diseases2
Coronary Restenosis2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.